Viewing Study NCT04406168


Ignite Creation Date: 2025-12-24 @ 5:48 PM
Ignite Modification Date: 2025-12-24 @ 5:48 PM
Study NCT ID: NCT04406168
Status: UNKNOWN
Last Update Posted: 2020-05-28
First Post: 2020-05-10
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: Assessment of Urinary Diversions Outcomes Post Radical Cystectomy in Asyut University Urology Hospital
Sponsor: Assiut University
Organization:

Study Overview

Official Title: Assessment of Urinary Diversions Outcomes Post Radical Cystectomy in Asyut University Urology Hospital
Status: UNKNOWN
Status Verified Date: 2020-05
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Radical cystectomy (RC) for bladder cancer requires reconstruction of the lower urinary tract. Both continent and incontinent diversions are available for urinary reconstruction after RC. Types of urinary diversions include ( ileal conduit, uretero-cutaneous, ureterosigmoidostomy and orthotopic bladder) The decision process is complex and involves consideration of issues related to cancer stage, patient comorbidities, treatment needs, and patient desires related to Quality of life and intraoperative findings. Outcomes of urinary diversions include 1- survival rate (cancer specific or overall survival). 2- Oncological failure (local, distant or LNs). 3- Complications (perioperative, intraoperative or post-operative).

In this study, all these outcomes will be analyzed.
Detailed Description: None

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: True
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: False
Is an FDA AA801 Violation?: